Literature DB >> 27169222

Clinical Question: In adults with COPD does roflumilast reduce the frequency of exacerbations compDared to standard therapies aIone?

John Marshall Huser, Jeffrey Dean Hodgden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27169222      PMCID： PMC4896480     

Source DB:  PubMed          Journal:  J Okla State Med Assoc        ISSN： 0030-1876


× No keyword cloud information.
  3 in total

Review 1.  Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.

Authors:  Jimmy Chong; Phillippa Poole; Bonnie Leung; Peter N Black
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11

2.  Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.

Authors:  Fernando J Martinez; Peter M A Calverley; Udo-Michael Goehring; Manja Brose; Leonardo M Fabbri; Klaus F Rabe
Journal:  Lancet       Date:  2015-02-13       Impact factor: 79.321

Review 3.  Vulnerable COPD patients with comorbidities: the role of roflumilast.

Authors:  Melissa Lipari; Pramodini B Kale-Pradhan
Journal:  Ther Clin Risk Manag       Date:  2014-11-18       Impact factor: 2.423
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.